| __timestamp | AbbVie Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7724000000 | 1244910 |
| Thursday, January 1, 2015 | 6387000000 | 5029636 |
| Friday, January 1, 2016 | 5855000000 | 4846776 |
| Sunday, January 1, 2017 | 6275000000 | 5329003 |
| Monday, January 1, 2018 | 7399000000 | 7121000 |
| Tuesday, January 1, 2019 | 6942000000 | 9128000 |
| Wednesday, January 1, 2020 | 11299000000 | 10731000 |
| Friday, January 1, 2021 | 12349000000 | 10701000 |
| Saturday, January 1, 2022 | 15260000000 | 16121000 |
| Sunday, January 1, 2023 | 12872000000 | 37021000 |
| Monday, January 1, 2024 | 14752000000 |
Infusing magic into the data realm
In the world of pharmaceuticals, strategic spending on Selling, General, and Administrative (SG&A) expenses can be a key differentiator. Over the past decade, AbbVie Inc. and Viking Therapeutics, Inc. have showcased contrasting SG&A spending patterns. AbbVie, a giant in the industry, has seen its SG&A expenses grow by approximately 66% from 2014 to 2023, peaking in 2022. This reflects its aggressive market strategies and expansion efforts. In contrast, Viking Therapeutics, a smaller player, has increased its SG&A spending by nearly 2,900% over the same period, indicating its rapid growth and investment in market presence. While AbbVie's spending dwarfs Viking's, the latter's growth trajectory is noteworthy. These patterns highlight the diverse strategies companies employ to maintain competitiveness and drive growth in the ever-evolving pharmaceutical landscape.
Breaking Down SG&A Expenses: AbbVie Inc. vs AstraZeneca PLC
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Summit Therapeutics Inc.
Who Optimizes SG&A Costs Better? AbbVie Inc. or Blueprint Medicines Corporation
AbbVie Inc. or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?
Novartis AG and Viking Therapeutics, Inc.: SG&A Spending Patterns Compared
Insmed Incorporated or Viking Therapeutics, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Viking Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Viking Therapeutics, Inc. and Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Viking Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Comparing SG&A Expenses: Viking Therapeutics, Inc. vs MannKind Corporation Trends and Insights
Operational Costs Compared: SG&A Analysis of Viking Therapeutics, Inc. and Xencor, Inc.